Search
for
Sort by
Research 811–840 of 941
- Rapid Analysis of the Chemical Composition of Xiaoban Kangfu Capsules Based on UHPLC-Q-Exactive Orbitrap MS/MS Combined with Molecular Networks
- <i>GJB6</i> missense variant in a Labrador Retriever with paw pad hyperkeratosis
- Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review
- ALOPECIA AREATA: ASPECTOS FISIOLÓGICOS E AVANÇOS TERAPÊUTICOS – UMA REVISÃO DE LITERATURA
- Can Plant Extracts Help Prevent Hair Loss or Promote Hair Growth? A Review Comparing Their Therapeutic Efficacies, Phytochemical Components, and Modulatory Targets
- Phytotherapeutic Interventions using Rodent Models of Hair Loss: Current Research and Future Strategy
- The Rotterdam Study: objectives and design update
- Advances in skin grafting and treatment of cutaneous wounds
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Ethosomes: New Prospects in Transdermal Delivery
- Dermal β-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation
- Vitamin D receptor is essential for normal keratinocyte stem cell function
- Hyaluronate Fragments Reverse Skin Atrophy by a CD44-Dependent Mechanism
- Frizzled Receptors in Development and Disease
- Management of Post-Acne Scarring
- Long-term expansion and differentiation of adult murine epidermal stem cells in 3D organoid cultures
- The proteomics of keratin proteins
- Extra-Intestinal Manifestation of Celiac Disease in Children
- Efficient In Vivo Targeting of Epidermal Stem Cells by Early Gestational Intraamniotic Injection of Lentiviral Vector Driven by the Keratin 5 Promoter
- Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Long and short non-coding RNA and radiation response: a review
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Myotonic Dystrophy—A Progeroid Disease?
- Distinct Phenotypic and Genomic Signatures Underlie Contrasting Pathogenic Potential of Staphylococcus epidermidis Clonal Lineages
- Natural Sources of Therapeutic Agents Used in Skin Conditions
- Pervasive structural racism in environmental epidemiology
- Direct Vasodilators and Sympatholytic Agents